Close Menu

NEW YORK – Finnish molecular diagnostics firm Mobidiag said on Tuesday that its Novodiag COVID-19 and Amplidiag COVID-19 PCR tests have received CE-IVD marking.

The Novodiag COVID-19 test uses nasopharyngeal swabs to detect the SARS-CoV-2 orf1ab and N genes and runs on Mobidiag's Novodiag rapid fully automated system, providing results in an hour. The company noted that its platform is user friendly and closed, which means it can protect users from contamination and can be used in decentralized areas.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

IBM security researchers warn of a phishing campaign targeted at organizations involved in the distribution of SARS-CoV-2 vaccines, the Verge reports.

The Illinois police have cut the number of DNA tests waiting to be run in about half, CBS Chicago reports.

A researcher accused of smuggling research materials out of the US has pleaded guilty to making false statements, according to the Associated Press.

In Science this week: gene expression signature linked to nonalcoholic fatty liver disease progression, and more.